The New York Attorney General’s office is asking the Food and Drug Administration (FDA) to double down on its warnings and discourage the use of an asthma drug. “The New York Office of the Attorney General writes to encourage the FDA to address the dangers of montelukast, particularly to the most vulnerable population—minor children—and protect all patients from these heartbreaking, unintended side effects,” Darsana Srinivasan, chief of the Office of the Attorney General’s Health Care Bureau, wrote in a Thursday letter addressed to FDA Commissioner Robert Califf. Srinivasan noted that “[i]t has been nearly four years since” the FDA “strengthened existing warnings regarding the menta
Hence then, the article about new york ag asks fda to double down on warnings discourage prescription for asthma drug was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( New York AG asks FDA to double down on warnings, discourage prescription for asthma drug )